1403015 Informal Interpretation
Date
Rule
801.2
Agree. KW & DG concur.
File
Original Image File
(482.23 KB)
Displaying 2941 - 2960 of 4793
FTC Approves Nielsen Holdings N.V. and Nielsen Audio, Inc.’s Application to Sell its LinkMeter Technology and Related Assets to comScore, Inc.
Date
Following a public comment period, the Federal Trade Commission has approved an application by Nielsen Holdings N.V. and Nielsen Audio, Inc. (collectively, Nielsen) to sell its LinkMeter cross...
FTC Approves Final Order Settling Charges that Thermo Fisher’s Acquisition of Life Technologies Corporation Was Anticompetitive
Date
Following a public comment period, the Federal Trade Commission has approved a final consent order settling charges that Thermo Fisher Scientific Inc.’s acquisition of Life Technologies Corporation...
Thermo Fisher Scientific Inc., In the Matter of
Thermo Fisher Scientific Inc. agreed to sell assets to GE Healthcare to settle Federal Trade Commission charges that its proposed $13.6 billion acquisition of Life Technologies Corporation (Life) would likely substantially lessen competition.The FTC complaint alleged that the deal, as it was originally proposed, would have eliminated close competition between Thermo Fisher and Life and substantially increased concentration in the markets for short/small interfering ribonucleic acid (siRNA) reagents, cell culture media, and cell culture sera, enabling the combined firm to raise prices and reduce quality for consumers. The proposed order settling the FTC’s charges requires Thermo Fisher to divest its gene modulation business Dharmacon, which contains the siRNA reagents business, as well as its cell culture media and sera business including the HyClone brand to GE Healthcare, along with all intellectual property and know-how necessary to operate each of the divested businesses.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
131 0134
Docket Number
C-4431
Nielsen Holdings N.V., and Arbitron Inc., In the Matter of
Media research company Nielsen Holdings N.V. settled charges that its acquisition of Arbitron Inc. may substantially lessen competition for national syndicated cross-platform audience measurement services. Nielsen and Arbitron are the best-positioned firms to develop (or partner with others to develop) a national syndicated cross-platform audience measurement service because of their existing audience measurement panels and proven audience measurement technology assets. To settle the charges, the Commission required the divestiture of assets related to Arbitron’s cross-platform audience measurement business, including data from its representative panel, to a Commission-approved buyer.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
131 0058
Public Statement
FTC Bureau of Competition Director’s Report - Spring 2014
Date
File
BC Director’s Report Spring 2014
(211.7 KB)
FTC Chairwoman Releases 2013 Annual Highlights
Date
Federal Trade Commission Chairwoman Edith Ramirez released the agency’s 2013 Annual Highlights today at the Spring Meeting of the American Bar Association’s Section of Antirust Law in Washington...
FTC Charges Two Leading Suppliers of Propane Exchange Tanks with Restraining Competition
Date
The Federal Trade Commission issued an administrative complaint against Ferrellgas Partners, L.P and Ferrellgas, L.P. (doing business as Blue Rhino) and UGI Corporation and AmeriGas Partners, L.P....
FTC Staff Comments on Illinois Senate Bill to Repeal Prohibition on Sunday Auto Sales
Date
Federal Trade Commission staff, in response to a request from State Senator James Oberweis, provided written comments to the Illinois State Senate on the competitive impact of repealing the state’s...
1403014 Informal Interpretation
Date
Rule
801.1(b)
Agree. KW concurs.
File
Original Image File
(393.49 KB)
FTC To Host Symposium in Celebration of Agency’s Centennial
Date
The year 2014 marks 100 years since President Woodrow Wilson signed the Federal Trade Commission Act, which established the Commission and serves as the keystone of the agency’s efforts to protect...
FTC Requests Public Comments on SCI’s Application to Approve Sale of Funeral Assets in Florida, North Carolina, Pennsylvania, and Virginia to StoneMor L.P. and its Subsidiaries
Date
The Federal Trade Commission is currently accepting public comments on an application by Service Corporation International (SCI) to sell certain funeral and cemetery assets, as required under the FTC...
U.S. and Canadian Antitrust Agencies Issue Best Practices for Coordinating Merger Reviews
Date
The Federal Trade Commission, the Department of Justice, and the Competition Bureau Canada today issued a set of “best practices” to make more transparent how they coordinate merger reviews that...
1403013 Informal Interpretation
Date
Rule
801.12
(Refer to image file for calculations)
File
Original Image File
(195.54 KB)
FTC Puts Conditions on CoreLogic, Inc.’s Proposed Acquisition of DataQuick Information Systems
Date
CoreLogic, Inc. has agreed to settle Federal Trade Commission charges that its proposed $661 million acquisition of DataQuick Information Systems, Inc. from TPG VI Ontario 1 AIV L.P. (TPG) would...
FTC Approves Final Order Settling Charges that Endo Health Solutions’ Acquisition of Boca Life Sciences Was Anticompetitive
Date
Following a public comment period, the Federal Trade Commission has approved a final consent order settling charges that Endo Health Solutions’ acquisition of Boca Life Sciences would likely reduce...
Endo Health Solutions Inc., Boca Life Science Holdings, LLC, and Boca Pharmacal, LLC, In the Matter of
Pharmaceutical companies Endo Health Sciences Inc. (Endo) and Boca Life Science Holdings, LLC and Boca Pharmacal, LLC (Boca) agreed to a settlement resolving FTC charges that Endo’s acquisition of Boca would be anticompetitive. Under the settlement, the companies will relinquish their rights to market and distribute four generic multivitamin fluoride drops for children, and will sell three other generic drugs in development.The proposed settlement preserves competition in the pharmaceutical markets for four prescription generic multivitamin drop products given to children in the United States who do not have access to fluoridated water. In addition, the FTC’s settlement preserves future competition for three generic drugs where the proposed acquisition would eliminate one likely future entrant from a very limited pool of future entrants.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
131 0225
Docket Number
C-4430
1403011 Informal Interpretation
Date
Rule
802.9
All four of these are inconsistent with 802.9. We have set a bright line that holding more than 10% of a competitor either by the target (of a competitor of the acquiring person) or the acquiring...
File
Original Image File
(112.56 KB)
1403009 Informal Interpretation
Date
Rule
Form Item 5
1. The revenues from graphic design services that are provided outside of the US would not be reported in Item 5 even if the customer is located in the US. 2. Non-manufacturing revenues derived from...
File
Original Image File
(131.4 KB)
Displaying 2941 - 2960 of 4793